hu liu
Anhui Provincial Cancer Hospital
Hefei, China
Review Editor
Pharmacology of Anti-Cancer Drugs
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
1,064 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
jing-yuan liu
University of Toledo
Toledo, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
tian liu
Dalian University of Technology
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
tianqing liu
Western Sydney University
Penrith, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
wukun liu
Nanjing University of Chinese Medicine
Nanjing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
xinli liu
College of Pharmacy, University of Houston
Houston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
xuefeng liu
The Ohio State University
Columbus, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
yajun liu
Dalian University of Technology
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
marcello locatelli
University of Studies G. d'Annunzio Chieti and Pescara
Chieti, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
alessio lodola
University of Parma
Parma, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
enza lonardo
Institute of Genetics and Biophysics Adriano Buzzati-Traverso, Department of Biomedical Sciences, National Research Council (CNR)
Naples, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
chi-cheng lu
National Taiwan University of Sport
Taichung, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
li lu
Capital Medical University
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
xin lu
University of Notre Dame
Notre Dame, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
donatella lucchetti
Catholic University of the Sacred Heart
Milano, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
amarjit luniwal
North American Science Associates Inc.
Northwood, United States
Review Editor
Pharmacology of Anti-Cancer Drugs